Persistent Coronavirus Disease 2019 (COVID‐19) in Patients With Malignant Lymphoma Treated With Anti‐CD20 Antibodies Who Responded to Ensitrelvir: A Report of Three Cases
Mika Horie, Tamio Okimoto, Yusuke Okada, Masaya Inoue, Shintaro Shimizu, Hirotoki Tsuda et al. Persistent Coronavirus Disease 2019 (COVID‐19) in Patients With Malignant Lymphoma Treated With Anti‐CD20 Antibodies Who Responded to Ensitrelvir: A Report of Three Cases. // Respirology Case Reports. – 2026. – DOI: 10.1002/rcr2.70804. – URL: https://onlinelibrary.wiley.com/doi/10.1002/rcr2.70804?af=R
Mika Horie, Tamio Okimoto, Yusuke Okada, Masaya Inoue, Shintaro Shimizu, Hirotoki Tsuda, Kojiro Hata, Takae Okuno, Yoshihiro Amano, Mika Nakao, Kazuhisa Nakashima, Megumi Hamaguchi, & Takeshi Isobe (2026). Persistent Coronavirus Disease 2019 (COVID‐19) in Patients With Malignant Lymphoma Treated With Anti‐CD20 Antibodies Who Responded to Ensitrelvir: A Report of Three Cases. Respirology Case Reports. https://doi.org/10.1002/rcr2.70804
Mika Horie, et al. “Persistent Coronavirus Disease 2019 (COVID‐19) in Patients With Malignant Lymphoma Treated With Anti‐CD20 Antibodies Who Responded to Ensitrelvir: A Report of Three Cases.” Respirology Case Reports, 2026. doi:10.1002/rcr2.70804.
@article{Horie2026,
title = {Persistent Coronavirus Disease 2019 (COVID‐19) in Patients With Malignant Lymphoma Treated With Anti‐CD20 Antibodies Who Responded to Ensitrelvir: A Report of Three Cases},
author = {Horie, Mika and Okimoto, Tamio and Okada, Yusuke and Inoue, Masaya and Shimizu, Shintaro and Tsuda, Hirotoki and Hata, Kojiro and Okuno, Takae and Amano, Yoshihiro and Nakao, Mika and Nakashima, Kazuhisa and Hamaguchi, Megumi and Isobe, Takeshi},
journal = {Respirology Case Reports},
year = {2026},
doi = {10.1002/rcr2.70804},
url = {https://onlinelibrary.wiley.com/doi/10.1002/rcr2.70804?af=R}
}